1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vendor Neutral Archive (VNA) and PACS Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cloud-hosted
1.2.3 On-Site (Premise)
1.2.4 Hybrid
1.3 Market by Application
1.3.1 Global Vendor Neutral Archive (VNA) and PACS Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Enterprise
1.3.3 Cardiology
1.3.4 Radiology
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Vendor Neutral Archive (VNA) and PACS Market Perspective (2017-2028)
2.2 Vendor Neutral Archive (VNA) and PACS Growth Trends by Region
2.2.1 Vendor Neutral Archive (VNA) and PACS Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Vendor Neutral Archive (VNA) and PACS Historic Market Size by Region (2017-2022)
2.2.3 Vendor Neutral Archive (VNA) and PACS Forecasted Market Size by Region (2023-2028)
2.3 Vendor Neutral Archive (VNA) and PACS Market Dynamics
2.3.1 Vendor Neutral Archive (VNA) and PACS Industry Trends
2.3.2 Vendor Neutral Archive (VNA) and PACS Market Drivers
2.3.3 Vendor Neutral Archive (VNA) and PACS Market Challenges
2.3.4 Vendor Neutral Archive (VNA) and PACS Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vendor Neutral Archive (VNA) and PACS Players by Revenue
3.1.1 Global Top Vendor Neutral Archive (VNA) and PACS Players by Revenue (2017-2022)
3.1.2 Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Players (2017-2022)
3.2 Global Vendor Neutral Archive (VNA) and PACS Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vendor Neutral Archive (VNA) and PACS Revenue
3.4 Global Vendor Neutral Archive (VNA) and PACS Market Concentration Ratio
3.4.1 Global Vendor Neutral Archive (VNA) and PACS Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vendor Neutral Archive (VNA) and PACS Revenue in 2021
3.5 Vendor Neutral Archive (VNA) and PACS Key Players Head office and Area Served
3.6 Key Players Vendor Neutral Archive (VNA) and PACS Product Solution and Service
3.7 Date of Enter into Vendor Neutral Archive (VNA) and PACS Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vendor Neutral Archive (VNA) and PACS Breakdown Data by Type
4.1 Global Vendor Neutral Archive (VNA) and PACS Historic Market Size by Type (2017-2022)
4.2 Global Vendor Neutral Archive (VNA) and PACS Forecasted Market Size by Type (2023-2028)
5 Vendor Neutral Archive (VNA) and PACS Breakdown Data by Application
5.1 Global Vendor Neutral Archive (VNA) and PACS Historic Market Size by Application (2017-2022)
5.2 Global Vendor Neutral Archive (VNA) and PACS Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Vendor Neutral Archive (VNA) and PACS Market Size (2017-2028)
6.2 North America Vendor Neutral Archive (VNA) and PACS Market Size by Type
6.2.1 North America Vendor Neutral Archive (VNA) and PACS Market Size by Type (2017-2022)
6.2.2 North America Vendor Neutral Archive (VNA) and PACS Market Size by Type (2023-2028)
6.2.3 North America Vendor Neutral Archive (VNA) and PACS Market Share by Type (2017-2028)
6.3 North America Vendor Neutral Archive (VNA) and PACS Market Size by Application
6.3.1 North America Vendor Neutral Archive (VNA) and PACS Market Size by Application (2017-2022)
6.3.2 North America Vendor Neutral Archive (VNA) and PACS Market Size by Application (2023-2028)
6.3.3 North America Vendor Neutral Archive (VNA) and PACS Market Share by Application (2017-2028)
6.4 North America Vendor Neutral Archive (VNA) and PACS Market Size by Country
6.4.1 North America Vendor Neutral Archive (VNA) and PACS Market Size by Country (2017-2022)
6.4.2 North America Vendor Neutral Archive (VNA) and PACS Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Vendor Neutral Archive (VNA) and PACS Market Size (2017-2028)
7.2 Europe Vendor Neutral Archive (VNA) and PACS Market Size by Type
7.2.1 Europe Vendor Neutral Archive (VNA) and PACS Market Size by Type (2017-2022)
7.2.2 Europe Vendor Neutral Archive (VNA) and PACS Market Size by Type (2023-2028)
7.2.3 Europe Vendor Neutral Archive (VNA) and PACS Market Share by Type (2017-2028)
7.3 Europe Vendor Neutral Archive (VNA) and PACS Market Size by Application
7.3.1 Europe Vendor Neutral Archive (VNA) and PACS Market Size by Application (2017-2022)
7.3.2 Europe Vendor Neutral Archive (VNA) and PACS Market Size by Application (2023-2028)
7.3.3 Europe Vendor Neutral Archive (VNA) and PACS Market Share by Application (2017-2028)
7.4 Europe Vendor Neutral Archive (VNA) and PACS Market Size by Country
7.4.1 Europe Vendor Neutral Archive (VNA) and PACS Market Size by Country (2017-2022)
7.4.2 Europe Vendor Neutral Archive (VNA) and PACS Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Size (2017-2028)
8.2 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Size by Type
8.2.1 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Share by Type (2017-2028)
8.3 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Size by Application
8.3.1 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Share by Application (2017-2028)
8.4 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Size by Region
8.4.1 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Vendor Neutral Archive (VNA) and PACS Market Size (2017-2028)
9.2 Latin America Vendor Neutral Archive (VNA) and PACS Market Size by Type
9.2.1 Latin America Vendor Neutral Archive (VNA) and PACS Market Size by Type (2017-2022)
9.2.2 Latin America Vendor Neutral Archive (VNA) and PACS Market Size by Type (2023-2028)
9.2.3 Latin America Vendor Neutral Archive (VNA) and PACS Market Share by Type (2017-2028)
9.3 Latin America Vendor Neutral Archive (VNA) and PACS Market Size by Application
9.3.1 Latin America Vendor Neutral Archive (VNA) and PACS Market Size by Application (2017-2022)
9.3.2 Latin America Vendor Neutral Archive (VNA) and PACS Market Size by Application (2023-2028)
9.3.3 Latin America Vendor Neutral Archive (VNA) and PACS Market Share by Application (2017-2028)
9.4 Latin America Vendor Neutral Archive (VNA) and PACS Market Size by Country
9.4.1 Latin America Vendor Neutral Archive (VNA) and PACS Market Size by Country (2017-2022)
9.4.2 Latin America Vendor Neutral Archive (VNA) and PACS Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size (2017-2028)
10.2 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size by Type
10.2.1 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Share by Type (2017-2028)
10.3 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size by Application
10.3.1 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Share by Application (2017-2028)
10.4 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size by Country
10.4.1 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Agfa Healthcare NV
11.1.1 Agfa Healthcare NV Company Details
11.1.2 Agfa Healthcare NV Business Overview
11.1.3 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Introduction
11.1.4 Agfa Healthcare NV Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.1.5 Agfa Healthcare NV Recent Developments
11.2 Dell Technologies
11.2.1 Dell Technologies Company Details
11.2.2 Dell Technologies Business Overview
11.2.3 Dell Technologies Vendor Neutral Archive (VNA) and PACS Introduction
11.2.4 Dell Technologies Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.2.5 Dell Technologies Recent Developments
11.3 Fujifilm Holdings Corporation
11.3.1 Fujifilm Holdings Corporation Company Details
11.3.2 Fujifilm Holdings Corporation Business Overview
11.3.3 Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Introduction
11.3.4 Fujifilm Holdings Corporation Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.3.5 Fujifilm Holdings Corporation Recent Developments
11.4 GE Healthcare
11.4.1 GE Healthcare Company Details
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Vendor Neutral Archive (VNA) and PACS Introduction
11.4.4 GE Healthcare Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.4.5 GE Healthcare Recent Developments
11.5 IBM Corporation
11.5.1 IBM Corporation Company Details
11.5.2 IBM Corporation Business Overview
11.5.3 IBM Corporation Vendor Neutral Archive (VNA) and PACS Introduction
11.5.4 IBM Corporation Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.5.5 IBM Corporation Recent Developments
11.6 Koninklijke Philips NV
11.6.1 Koninklijke Philips NV Company Details
11.6.2 Koninklijke Philips NV Business Overview
11.6.3 Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Introduction
11.6.4 Koninklijke Philips NV Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.6.5 Koninklijke Philips NV Recent Developments
11.7 Lexmark International
11.7.1 Lexmark International Company Details
11.7.2 Lexmark International Business Overview
11.7.3 Lexmark International Vendor Neutral Archive (VNA) and PACS Introduction
11.7.4 Lexmark International Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.7.5 Lexmark International Recent Developments
11.8 McKesson Corporation
11.8.1 McKesson Corporation Company Details
11.8.2 McKesson Corporation Business Overview
11.8.3 McKesson Corporation Vendor Neutral Archive (VNA) and PACS Introduction
11.8.4 McKesson Corporation Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.8.5 McKesson Corporation Recent Developments
11.9 Novarad Corporation
11.9.1 Novarad Corporation Company Details
11.9.2 Novarad Corporation Business Overview
11.9.3 Novarad Corporation Vendor Neutral Archive (VNA) and PACS Introduction
11.9.4 Novarad Corporation Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.9.5 Novarad Corporation Recent Developments
11.10 Siemens
11.10.1 Siemens Company Details
11.10.2 Siemens Business Overview
11.10.3 Siemens Vendor Neutral Archive (VNA) and PACS Introduction
11.10.4 Siemens Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.10.5 Siemens Recent Developments
11.11 TeraMedica
11.11.1 TeraMedica Company Details
11.11.2 TeraMedica Business Overview
11.11.3 TeraMedica Vendor Neutral Archive (VNA) and PACS Introduction
11.11.4 TeraMedica Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.11.5 TeraMedica Recent Developments
11.12 Merge Health
11.12.1 Merge Health Company Details
11.12.2 Merge Health Business Overview
11.12.3 Merge Health Vendor Neutral Archive (VNA) and PACS Introduction
11.12.4 Merge Health Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.12.5 Merge Health Recent Developments
11.13 BridgeHead
11.13.1 BridgeHead Company Details
11.13.2 BridgeHead Business Overview
11.13.3 BridgeHead Vendor Neutral Archive (VNA) and PACS Introduction
11.13.4 BridgeHead Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.13.5 BridgeHead Recent Developments
11.14 Carestream Health
11.14.1 Carestream Health Company Details
11.14.2 Carestream Health Business Overview
11.14.3 Carestream Health Vendor Neutral Archive (VNA) and PACS Introduction
11.14.4 Carestream Health Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.14.5 Carestream Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
